Satsuma Pharmaceuticals, Inc.
USD1.10
+0.00 (+0.00%)
CEO
John A. Kollins MBA
IPO Date
2019-09-13
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.11
Prev. Close
$1.10
Day Low
$1.10
Day High
$1.10
52W Low
$0.59
52W High
$8.08
Market Cap
$0.04B
Volume
1.83M
| 10,000 |
| $26.99 |
| 12 Jun 2023 | RA CAPITAL MANAGEMENT, L.P. | — | D-Return | Disposed | 20,000 | $4.60 |
| 12 Jun 2023 | RA CAPITAL MANAGEMENT, L.P. | — | D-Return | Disposed | 30,000 | $3.46 |
| 8 Jun 2023 | Harsch Mutya | director | D-Return | Disposed | 30,000 | $3.46 |
| 8 Jun 2023 | Harsch Mutya | director | D-Return | Disposed | 40,000 | $4.48 |
| 8 Jun 2023 | Kollins John A | director, officer: President and CEO | D-Return | Disposed | 175,000 | $29.00 |
| 8 Jun 2023 | Kollins John A | director, officer: President and CEO | D-Return | Disposed | 240,000 | $4.60 |
| 8 Jun 2023 | Kollins John A | director, officer: President and CEO | D-Return | Disposed | 505,000 | $3.46 |
| 8 Jun 2023 | Kollins John A | director, officer: President and CEO | D-Return | Disposed | 276,595 | $4.56 |